Abstract: A disclosed transmitter for wireless communication includes multiple transmitting antennas, a symbol mapper for mapping an input block including multiple binary bits and representing information to be transmitted to a symbol representing an ordered plurality of complex numbers, a space-time encoder for applying an encoding operator to the symbol to produce a vectorized space-time codeword defining electrical signals to be transmitted by the transmitter, the encoding operator being dependent on a set of predefined stabilizer generators, and circuitry to collectively transmit, by the antennas to multiple receiving antennas of a receiver over a wireless transmission channel, the electrical signals defined by the vectorized space-time codeword. The receiver includes a space-time decoder for recovering the symbol from the electrical signals transmitted by the transmitter using a decoding operation that is based on maximum likelihood inference, and a symbol de-mapper for recovering the input block from the symbol.
Type:
Application
Filed:
December 29, 2021
Publication date:
April 21, 2022
Applicant:
Board of Regents, The University of Texas System
Inventors:
S. Andrew Lanham, Travis Cuvelier, Brian R. La Cour, Robert Heath
Abstract: Methods for treating Shiga toxicosis, caused by infection with Shiga toxin bacteria, are provided. The methods include administering to a subject in need thereof an effective amount of one or more active agents selected from tamoxifen, 4-hydroxytamoxifen, endoxifen, toremifene, raloxifene, bazedoxifene, and pharmaceutically acceptable salts thereof. In some embodiments, the methods further include the administration of an antibiotic or a manganese compound to the subject. Pharmaceutical compositions for the treatment of Shiga toxicosis are also described.
Type:
Grant
Filed:
June 2, 2020
Date of Patent:
April 19, 2022
Assignee:
Board of Regents, The University of Texas System
Inventors:
Somshuvra Mukhopadhyay, Andrey S. Selyunin, Stanton F. McHardy
Abstract: The present disclosure relates to an electrical energy storage apparatus which forms an interpenetrating, three dimensional structure. The structure may have a first non-planar channel filled with an anode material to form an anode, and a second non-planar channel adjacent the first non-planar channel filled with a cathode material to form a cathode. A third non-planar channel may be formed adjacent the first and second non-planar channels and filled with an electrolyte. The first, second and third channels are formed so as to be interpenetrating and form a spatially dense, three dimensional structure. A first current collector is in communication with the first non-planar channel and forms a first electrode, while a second current collector is in communication with the second non-planar channel and forms a second electrode. A separator layers separates the current collectors.
Type:
Grant
Filed:
November 20, 2015
Date of Patent:
April 19, 2022
Assignees:
Lawrence Livermore National Security, LLC, Board of Regents, The University of Texas System
Inventors:
Eric Duoss, Juergen Biener, Patrick Campbell, Julie A. Jackson, Geoffrey M. Oxberry, Christopher Spadaccini, Michael Stadermann, Cheng Zhu, Bradley Trembacki, Jayathi Murthy, Matthew Merrill
Abstract: The techniques described herein may provide an efficient and secure two-party distributed signing protocol, for example, for the IEEE P1363 standard. For example, in an embodiment, method may comprise generating, at a key generation center, a first partial private cryptographic key for a user ID and a second partial private cryptographic key for the user ID, transmitting the first partial private cryptographic key to a first other device, transmitting the second partial private cryptographic key to a second other device, and generating a distributed cryptographic signature for a message using the first partial private cryptographic key and the second partial private cryptographic key.
Type:
Grant
Filed:
November 19, 2019
Date of Patent:
April 19, 2022
Assignee:
Board of Regents, The University of Texas System
Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
Type:
Grant
Filed:
September 13, 2021
Date of Patent:
April 19, 2022
Assignee:
The Board of Regents of The University of Texas System
Inventors:
Qiang Cheng, Tuo Wei, Daniel J. Siegwart
Abstract: The present disclosure provides a method of preventing, treating, or inhibiting migraine in a subject, by administering to the subject an amount of first therapeutic selected from cercosporamide, eFT508, or 4EGI-1 sufficient to prevent, treat, or inhibit said migraine. The present disclosure further provides a composition including at least two of cercosporamide. eFT508, or 4EGI-1, both in an amount sufficient to prevent, treat, or inhibit migraine in a subject and a pharmaceutically acceptable carrier. The present disclosure further provides a composition including at least one of cercosporamide, eFT508, or 4EGI-1 and at least one additional migraine therapeutic, both in an amount sufficient to prevent, treat, or inhibit migraine in a subject, and a pharmaceutically acceptable carrier.
Type:
Application
Filed:
October 7, 2021
Publication date:
April 14, 2022
Applicant:
Board of Regents, The University of Texas System
Abstract: In this disclosure, collaborative multi-agent-based TST is presented with dedicated intersection controllers that include software agents which read local and remote detection systems and then collaboratively optimize signal timing phases by considering the feedback of all controller agents that may be affected by a change. The disclosure also presents an augmented system which considers network input from handheld remote devices to update certain traffic light phase information and adapt to emerging emergency situations.
Type:
Application
Filed:
December 23, 2021
Publication date:
April 14, 2022
Applicant:
Board of Regents, The University of Texas System
Abstract: An electrochemical reactor for use with a liquid electrolyte is capable of generating gaseous products. An electrically conducting porous layer that is hydrophilic on the catalyst side and hydrophobic on the gas side are utilized. These different surface properties promote the transport of product gases formed at the catalyst through the porous layer to the gas side. The catalyst is formed from a hybrid Cu2O—CuBr film that has a high selectivity for ethylene gas from reacting CO2 and water in an electrochemical cell.
Type:
Grant
Filed:
January 29, 2019
Date of Patent:
April 12, 2022
Assignee:
Board of Regents, The University of Texas System
Inventors:
Norma S. Tacconi, Wilaiwan Chanmanee, Brian Dennis, Krishnan Rajeshwar
Abstract: Provided herein are chimeric antigen receptors (CARs) comprising a glucuronoxylomannan receptor antigen-binding domain. Further provided herein are immune cells expressing the GXMR-CARs as well as methods of their use in the treatment of cryptococcosis.
Type:
Application
Filed:
February 7, 2020
Publication date:
April 7, 2022
Applicant:
Board of Regents, The University of Texas System
Inventors:
Pappanaicken KUMAR, Thiago APARECIDO DA SILVA, Paul J. HAUSER
Abstract: The techniques described herein may provide techniques to detect, categorize, and diagnose synchronization issues that provide improved performance and issue resolution. For example, in an embodiment, a method may comprise detecting occurrence of synchronization performance problems in software code, when at least some detected synchronization performance problems occur when a contention rate for software locks is low, determining a cause of the synchronization performance problems, and modifying the software code to remedy the cause of the synchronization performance problems so as to improve synchronization performance of the software code.
Type:
Grant
Filed:
April 16, 2019
Date of Patent:
April 5, 2022
Assignee:
The Board of Regents of The University of Texas System
Inventors:
Tongping Liu, Mohammad Mejbah ul Alam, Abdullah Al Muzahid
Abstract: Provided are antisense oligonucleotides targeted against bacterial genes involved in biochemical pathways and/or cellular processes, and related compositions and methods of using the oligonucleotides and compositions, alone or in combination with other antimicrobial agents, for instance, in the treatment of an infected mammalian subject.
Type:
Grant
Filed:
December 23, 2015
Date of Patent:
April 5, 2022
Assignees:
Board of Regents, The University of Texas System, Oregon State University
Abstract: Provided herein are cyclic peptide inhibitors of autophagy that bind to LC3. These cyclic peptides may be used to treat diseases or disorders associated with autophagy, such as, for example, cancer, diabetes, cardiovascular disease, and neurological disorders. These cyclic peptides may also be used to sensitize cancers to front-line chemotherapy, immunotherapy, and/or radiation therapy.
Type:
Application
Filed:
January 30, 2020
Publication date:
March 31, 2022
Applicant:
Board of Regents, The University of Texas System
Abstract: The present disclosure provides ammonium compounds, e.g., compounds according to Formula I as set forth herein, which are useful as antimicrobial agents. Methods for the treatment of bacterial infections and associated conditions, e.g., gastrointestinal conditions, are also described, as well as methods for altering the microbiome of subjects such as humans.
Type:
Application
Filed:
February 5, 2020
Publication date:
March 31, 2022
Applicant:
Board of Regents, The University of Texas System
Inventors:
Bryan Davies, Stanton McHardy, Ashley Cunningham, Hua-Yu Wang
Abstract: Provided is a method of detecting the presence of an anti-Zika virus (ZIKV) antibody in a sample, including contacting a sample with a suspension having a plurality of microspheres wherein individual microspheres are conjugated to a peptide and the peptide includes a ZIKV peptide selected from the group including ZIKV NS1, ZIKV NS5, and ZIKV envelope protein, forming a first incubated suspension by incubating said sample with said suspension to permit binding of anti-ZIKV antibodies present in the sample to said microspheres, forming a second incubated suspension by contacting said first incubated suspension with an anti-ZIKV antibody detecting-reagent to permit binding of the anti-ZIKV antibody detecting reagent to said microspheres, removing from the second incubated suspension anti-ZIKV antibody detecting-reagent molecules that are not bound to said microspheres, and detecting the presence of anti-ZIKV antibody detecting-reagent molecules in the second incubated suspension.
Type:
Application
Filed:
November 29, 2021
Publication date:
March 31, 2022
Applicants:
Health Research, Inc., The Board of Regents of The University of Texas System
Abstract: A permeative amine/acid introduction device (PAID) is placed after a conventional KOH eluent suppressed conductometric anion chromatography (SCAC) system. The PAID converts the suppressed eluites from the acid form to the corresponding salt. For example, when the analytes are acids, they are converted to the corresponding ammonium salt (NR2H+HX?NR2H2++X?) and allows very weak acids HX (pKa?7.0) that cannot normally be detected by SCAC to be measured by a second conductivity detector following the PAID. Permeative reagent introduction is dilutionless, can be operated without pumps and provides good mixing with low band dispersion (as small as 30 ?L). An exemplary amine is diethylamine (DEA), which was chosen as the amine source due to its low pKb value (pKb 3.0), high vapor pressure, and low toxicity and low odor.
Type:
Grant
Filed:
December 13, 2016
Date of Patent:
March 29, 2022
Assignee:
Board of Regents, The University of Texas System
Inventors:
Purnendu K. Dasgupta, Charles Phillip Shelor, Hongzhu Liao
Abstract: The present disclosure describes the C-type lectin CLEC11a as a bone growth factor. Clec11a-deficient mice showed reduced bone volume and mineralization, while bone resorption remained unchanged. Administration of recombinant Clec11a systemically promoted bone formation in mice at risk for osteoporosis.
Type:
Grant
Filed:
April 18, 2016
Date of Patent:
March 29, 2022
Assignee:
The Board of Regents of The University of Texas System
Abstract: Methods for generating fraud detection rules based on transaction data may include receiving historical transaction data, associating tags with each transaction, generating decision trees having root nodes and child nodes operably connected to the respective root nodes, determining at least one primary rule and at least one set of secondary rules associated with the at least one primary rule based on relationships between features of the transactions, assigning primary rules and sets of secondary rules to the at least one decision tree to populate the tree, extracting a plurality of rule sets including at least one primary rule and one or more secondary rules, determining an ordering of the plurality of rule sets; and determining a subset of rule sets from the ordered plurality of rule sets against which subsequently received transactions are compared against to determine if the subsequent transactions are fraudulent.
Type:
Grant
Filed:
January 8, 2019
Date of Patent:
March 29, 2022
Assignees:
Visa International Service Association, Roard of Regents, The University of Texas System
Inventors:
Youxing Qu, Yiwei Cai, Dan Wang, Harishkumar Sundarji Majithiya, Roshni Ann Samuel, Susan Finnegan, Claudia Barcenas, Himanshu Chauhan
Abstract: In a drilling system, a control system coupled to a drilling rig controls a bottom hole assembly (BHA) to drill a borehole through a geological formation along a drilling path. The control system determines a present position of the BHA and calculates a toolface vector to create a convergence path from the present position of the BHA to a desired target path. The control system also receives geological information and compensates the toolface vector to account for an estimated geologic formation drift. The control system causes at least one control parameter to be modified in order to alter a drilling direction of the BHA based on the calculated toolface vector and transmits the at least one control parameter to the drilling rig to target the BHA in accordance with the calculated toolface vector. The control system iteratively performs this process until convergence with the desired target path is achieved.
Type:
Grant
Filed:
October 3, 2019
Date of Patent:
March 29, 2022
Assignees:
Motive Drilling Technologies, Inc., Board of Regents, The University of Texas System
Inventors:
Todd W. Benson, Teddy Chen, Sashmit Bhaduri
Abstract: A system for producing a three-dimensional object from a fluid medium includes image processing units. The fluid medium is configured to solidify when subjected to a prescribed light stimulation. Each image processing unit includes at least one light emitting source configured to emit light, and at least one minor system configured to reflect the light emitted by the light emitting source. The minor system includes a manipulating system for adjusting the direction of the emitted light, a control system for controlling the manipulating system, and at least one optical element configured to manipulate the emitted light and to project the emitted light onto an area of a surface of the fluid medium to form an image on the surface. The image processing units are configured to form corresponding images on the surface, and are configured to be movable at least in a lateral direction relative to the surface.
Type:
Application
Filed:
January 24, 2020
Publication date:
March 24, 2022
Applicants:
Adaptive 3D Technologies, LLC, Board of Regents, The University of Texas System
Inventors:
Walter VOIT, Benjamin LUND, Daniel ZAMORANO, Caleb LUND, Stephen KAY, Eric PARKER
Abstract: Provided herein are methods and reagents for treating cancer. Methods of treating cancer are provided, comprising administering to a patient in need thereof an effective amount of a DKK1 peptide-loaded MHC antibody provided herein. The methods can further include administering an effective amount of chemotherapy or immunotherapy to said patient.
Type:
Application
Filed:
February 3, 2020
Publication date:
March 24, 2022
Applicant:
Board of Regents, The University of Texas System